$70.50
-1.40[-1.95%]
At close: Apr 26
$70.50
0[0.00%]
After Hours: 7:13PM EDT
MetLife Stock (NYSE:MET), Analyst Ratings, Price Targets, Predictions
MetLife Inc has a consensus price target of $73.79, established from looking at the 70 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Wells Fargo, and Keefe, Bruyette & Woods on April 15, 2024, April 11, 2024, and April 10, 2024. With an average price target of $85 between Morgan Stanley, Wells Fargo, and Keefe, Bruyette & Woods, there's an implied 20.57% upside for MetLife Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Wells Fargo
Keefe, Bruyette & Woods
Piper Sandler
UBS
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for MetLife
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/15/2024 | MET | Buy Now | MetLife | $70.50 | 16.31% | Morgan Stanley | Nigel Dally | $80 → $82 | Maintains | Overweight | Get Alert |
| 04/11/2024 | MET | Buy Now | MetLife | $70.50 | 21.99% | Wells Fargo | Elyse Greenspan | $83 → $86 | Maintains | Overweight | Get Alert |
| 04/10/2024 | MET | Buy Now | MetLife | $70.50 | 23.4% | Keefe, Bruyette & Woods | Ryan Krueger | $82 → $87 | Maintains | Outperform | Get Alert |
| 04/05/2024 | MET | Buy Now | MetLife | $70.50 | 20.57% | Piper Sandler | John Barnidge | $74 → $85 | Maintains | Overweight | Get Alert |
| 02/06/2024 | MET | Buy Now | MetLife | $70.50 | 17.73% | Wells Fargo | Elyse Greenspan | $85 → $83 | Maintains | Overweight | Get Alert |
| 02/05/2024 | MET | Buy Now | MetLife | $70.50 | 16.31% | UBS | Brian Meredith | $87 → $82 | Maintains | Buy | Get Alert |
| 01/10/2024 | MET | Buy Now | MetLife | $70.50 | 23.4% | UBS | Brian Meredith | $84 → $87 | Maintains | Buy | Get Alert |
| 01/09/2024 | MET | Buy Now | MetLife | $70.50 | 13.48% | Goldman Sachs | Alex Scott | $70 → $80 | Maintains | Buy | Get Alert |
| 01/08/2024 | MET | Buy Now | MetLife | $70.50 | 13.48% | Goldman Sachs | Alex Scott | → $80 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2023 | MET | Buy Now | MetLife | $70.50 | 9.22% | Keefe, Bruyette & Woods | Ryan Krueger | $79 → $77 | Maintains | Outperform | Get Alert |
| 11/17/2023 | MET | Buy Now | MetLife | $70.50 | 0.71% | Barclays | Tracy Benguigui | → $71 | Reinstates | → Overweight | Get Alert |
| 11/02/2023 | MET | Buy Now | MetLife | $70.50 | 13.48% | Morgan Stanley | Nigel Dally | $79 → $80 | Maintains | Overweight | Get Alert |
| 10/06/2023 | MET | Buy Now | MetLife | $70.50 | 16.31% | JP Morgan | Jimmy Bhullar | $85 → $82 | Maintains | Overweight | Get Alert |
| 09/14/2023 | MET | Buy Now | MetLife | $70.50 | 2.13% | Jefferies | Suneet Kamath | $58 → $72 | Upgrade | Hold → Buy | Get Alert |
| 08/18/2023 | MET | Buy Now | MetLife | $70.50 | 12.06% | Morgan Stanley | Nigel Dally | $78 → $79 | Maintains | Overweight | Get Alert |
| 08/15/2023 | MET | Buy Now | MetLife | $70.50 | 17.73% | Wells Fargo | Elyse Greenspan | $82 → $83 | Maintains | Overweight | Get Alert |
| 08/14/2023 | MET | Buy Now | MetLife | $70.50 | 9.22% | Argus Research | Kevin Heal | $70 → $77 | Maintains | Buy | Get Alert |
| 08/09/2023 | MET | Buy Now | MetLife | $70.50 | 14.89% | Citigroup | Michael Ward | $76 → $81 | Maintains | Buy | Get Alert |
| 08/04/2023 | MET | Buy Now | MetLife | $70.50 | 4.96% | RBC Capital | Mark Dwelle | $70 → $74 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for MetLife (MET)?
The latest price target for MetLife (NYSE: MET) was reported by Morgan Stanley on April 15, 2024. The analyst firm set a price target for $82.00 expecting MET to rise to within 12 months (a possible 16.31% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MetLife (MET)?
The latest analyst rating for MetLife (NYSE: MET) was provided by Morgan Stanley, and MetLife maintained their overweight rating.
When was the last upgrade for MetLife (MET)?
The last upgrade for MetLife Inc happened on January 8, 2024 when Goldman Sachs raised their price target to $80. Goldman Sachs previously had a neutral for MetLife Inc.
When was the last downgrade for MetLife (MET)?
The last downgrade for MetLife Inc happened on January 9, 2023 when Goldman Sachs changed their price target from $80 to $78 for MetLife Inc.
When is the next analyst rating going to be posted or updated for MetLife (MET)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MetLife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MetLife was filed on April 15, 2024 so you should expect the next rating to be made available sometime around April 15, 2025.
Is the Analyst Rating MetLife (MET) correct?
While ratings are subjective and will change, the latest MetLife (MET) rating was a maintained with a price target of $80.00 to $82.00. The current price MetLife (MET) is trading at is $70.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.